Vaccine Supply Modelling for India: Supplies set to improve

As India grapples with the devastating and deadly Covid-19 second wave, the vaccination drive has come as a glimmer of hope. But there are many questions surrounding this biggest drive in the world primarily around capacity and pricing.
To answer these questions Swapna Bhandarkar spoke with Anshuman Gupta, India's leading pharma analyst. Anshuman recently released a research report titled - India Pharmaceuticals: Vaccine Supply Modelling for India: Supplies set to improve. The report is supported by a detailed Working Excel Model that takes into account various factors that will aid the vaccination drive in India.